• Contact Us
  • Submit RFI/RFP
  • Trust Center
  • Ethics Hotline (report a violation)
  • LIFE SCIENCES
  • HEALTHCARE
  • RESOURCES
    • The Future Prescription
    • Blog
    • Case Studies & Publications
    • Events
    • Press Releases
  • ABOUT
    • Leadership
    • Board of Directors
    • Our Vision and Mission
    • Careers
    • Locations
  • SIGN IN
    • TriNetX LIVE™
    • EVIDEX®
  • Trial Design
  • Datasets & Analytics
  • Non-US Oncology
  • RWE Generation
  • Drug Safety

East Lancashire Hospitals NHS Trust Joins TriNetX to Improve Research Capabilities and Attract More Clinical Trial Opportunities

Sep 12, 2019 | Press Releases

Cambridge, MA, Sept. 12, 2019 — East Lancashire Hospitals NHS Trust (ELHT), a large integrated healthcare organization serving over a half million patients in north west England, has joined the TriNetX global health research network to improve its research...

Raleigh Neurology Associates Brings Specialty Clinical Data Set to the TriNetX Research Network

Jul 23, 2019 | Press Releases

Cambridge, MA, July 23, 2019 — Raleigh Neurology Associates (RNA), one of the largest private neurology practices in the U.S, has joined the TriNetX global health research network adding a significant new clinical data set to the world’s largest research network. “As...

TriNetX Applauds House Appropriations Committee for Supporting Use of Real-World Evidence in House Agriculture-FDA Spending Bill

Jun 13, 2019 | Press Releases

Cambridge, MA, June 13, 2019 — TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today praised the House Appropriations Committee for approving its fiscal year...

University of Rochester Medical Center Seeks Accelerated Access to Clinical Trials by Joining the TriNetX Network

May 14, 2019 | Press Releases

Cambridge, MA, May 14, 2019 — The University of Rochester Medical Center (URMC), one of the nation’s leading academic medical centers, announced it has joined the TriNetX network to expand its access to advanced clinical trials. “Our goal is to bring high quality,...

TriNetX to Present at ISPOR 2019 on the Power of Real-World Data to Impact Research Across a Wide Variety of Therapeutic Areas

May 6, 2019 | Events, Press Releases

Cambridge, MA, May 6, 2019 — TriNetX, the global health research network that optimizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that it will present eight posters at the upcoming International...

TriNetX Delivers Public Comments on the Use of Real-World Evidence at the Reagan-Udall Foundation’s 2019 Annual Public Meeting

May 2, 2019 | Press Releases

Cambridge, MA, May 2, 2019 — TriNetX, the global health research network that optimizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today delivered public comments on the use of RWE at the Reagan-Udall Foundation’s...

Hungary’s University of Debrecen Joins TriNetX Network to Increase Collaboration and Growth in Commercial Clinical Studies

Apr 30, 2019 | Press Releases

Cambridge, MA, April 30, 2019 — The University of Debrecen, one of the oldest continuously operating institutions of higher medical education in Hungary, has joined the TriNetX global health research network to develop collaborative research partnerships with other...

TriNetX’s Real-World Data and Analytics Platform Used to Compare Antihypertensive Treatments and Cardiovascular Events; Findings Published in the Journal of Clinical Hypertension

Apr 18, 2019 | Press Releases

Cambridge, MA, April 18, 2019 — TriNetX, the global health research network that optimizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that the Journal of Clinical Hypertension has published its...

Journal of Clinical Hypertension – “First‐line treatment of essential hypertension: A real‐world analysis across four antihypertensive treatment classes”

Apr 13, 2019 | Published Research

This study was written by Manfred Stapff, MD, PhD, Chief Medical Officer at TriNetX, and Sarah Hilderbrand, MSc and published in the Journal of Clinical Hypertension describing how electronic medical records can be used to analyze and compare actual treatment...

TriNetX, InSite Unite to Establish World’s Largest Clinical Research Network

Apr 2, 2019 | Press Releases

Acquisition of Belgium-based Custodix Promises to Bring New Pharmaceutical-Sponsored Clinical Trials to Healthcare Organizations Throughout Europe Cambridge, MA, April 2, 2019 — TriNetX, Inc., the global health research network that revolutionizes clinical research...
« Older Entries
Next Entries »

SOLUTIONS

Clinical Trial Design & Optimization

Data Sets & Analytics

Non-US Oncology

Insights & Evidence Generation

Drug Safety & Pharmacovigilance

WHO WE SERVE

Life Sciences

Healthcare Organizations

RESOURCES

Explore TriNetX RWD

Conferences

Webinars

Publications

Case Studies

ENTERPRISE

Leadership

Board of Directors

Careers

Locations

EMAIL OPT-IN

Get the latest on product updates, services, events, expert insights, and top industry trends.

Subscribe now

ABOUT TRINETX, LLC

TriNetX operates the world’s broadest federated network of real-world data in partnership with healthcare providers and applies intelligence that accelerates innovation across the healthcare ecosystem. Through its self-service, HIPAA-, GDPR-, and LGPD-compliant platform of federated deidentified and anonymous electronic health record datasets and consulting partnerships, TriNetX empowers its global community to improve clinical trial protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation.

TriNetX, LLC complies with all applicable privacy laws. For more information please visit our Trust Center.

FOLLOW US

LinkedIn
© TriNetX, LLC All Rights Reserved.
Terms of Use
Privacy & Cookies
Do not sell or share my personal information